Change - Announcement of Cessation::Cessation of Interim Chief Financial Officer

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
14-Mar-2019 19:40:13
Status
New
Announcement Sub Title
Cessation of Interim Chief Financial Officer
Announcement Reference
SG190314OTHRE14D
Submitted By (Co./ Ind. Name)
Lim Hoi Leong
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Mr. Tan Zing Yuen has relinquished his role as the interim Chief Financial Officer with effect from 15 March 2019 and will assume the role of Chief Risk Officer and Director, Group Finance.

Additional Details

Name Of Person
Tan Zing Yuen
Age
64
Is effective date of cessation known?
Yes
If yes, please provide the date
15/03/2019
Detailed Reason (s) for cessation
Mr Wilson Sam has been appointed as Group Chief Financial Officer of the Company in place of Mr Tan Zing Yuen.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
15/03/2019
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
5
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Risk Officer and Director, Group Finance
Role and responsibilities
As Chief Risk Officer, Mr Tan will report to the Group Chief Executive Officer and his responsibilities will cover the risk management and internal controls of the Group. Mr Tan will report to the Group Chief Financial Officer in his role as Director, Group Finance covering the corporate finance, investor relations, corporate and regulatory compliance and financial and management reporting functions.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
NIL
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
50,000 shares 100,000 warrants in the Issuer
Past (for the last 5 years)
See attached
Present
See attached

Attachments